https://orcid.org/0000-0003-1321-7922
References
- Sinnappah KA, Kuan IHS, Thynne TRJ, et al. The pharmacokinetics of metformin in patients receiving intermittent haemodialysis. Br J Clin Pharmacol. 2020;86(7):1430–1443.
- Calello DP, Liu KD, Wiegand TJ, et al. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med. 2015;43(8):1716–1730.
- Panzer U, Kluge S, Kreymann G, et al. Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant. 2004;19(8):2157–2158.
- Friesecke S, Abel P, Kraft M, et al. Combined renal replacement therapy for severe metformin-induced lactic acidosis. Nephrol Dial Transplant. 2006;21(7):2038–2039.
- Reynolds HV, Pollock HHG, Apte YV, et al. Achieving high dialysis dose via continuous renal replacement therapy in the setting of metformin associated lactic acidosis. A case series. A A Pract. 2022;16(1):e01561.